SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-055871
Filing Date
2019-02-28
Accepted
2019-02-28 09:06:35
Documents
3
Period of Report
2019-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d698914d8k.htm 8-K 37154
2 EX-4.1 d698914dex41.htm EX-4.1 184523
3 GRAPHIC g698914snap0008.jpg GRAPHIC 44315
  Complete submission text file 0001193125-19-055871.txt   284177
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 19640687
SIC: 2834 Pharmaceutical Preparations